Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:SOC
NYSE:SOCOil and Gas

Sable Offshore (SOC) Is Down 5.6% After California Lawsuit Over Federal Oversight Shift Has The Bull Case Changed?

California’s attorney general has filed a lawsuit against the Trump administration challenging the federal reclassification and restart of Sable Offshore Corp.’s Las Flores oil pipelines, intensifying a long-running clash over regulatory control in the state. The case highlights an unusual tug-of-war between state and federal authorities, where emergency-based federal oversight is colliding with persistent local and environmental opposition to the project. We’ll now examine how this legal...
NYSE:CQP
NYSE:CQPOil and Gas

Does Cheniere Energy Partners' Base‑Plus‑Variable Payout Reveal a New Capital Strategy for CQP?

Cheniere Energy Partners, L.P. recently declared a quarterly cash distribution of US$0.830 per common unit, comprising a US$0.775 base and a US$0.055 variable component, payable on February 13, 2026, to unitholders of record as of February 9, 2026. The blend of a recurring base payout with a smaller variable element highlights how the partnership balances ongoing income needs with flexibility around its liquefied natural gas export operations and tax considerations for foreign investors. We...
TSE:6471
TSE:6471Machinery

Assessing NSK (TSE:6471) Valuation After A Strong 1 Year Share Price Rally

NSK stock performance snapshot NSK (TSE:6471) has caught investor attention after a strong run in the past 3 months and over the past year, prompting a closer look at how its recent returns line up with fundamentals. See our latest analysis for NSK. NSK's recent share price momentum has cooled slightly in the last week after a strong 30 day share price return of 8.1% and a 90 day gain of 31.3%, while the 1 year total shareholder return of 75.3% points to sustained interest in the stock over a...
NYSE:LVS
NYSE:LVSHospitality

Las Vegas Sands (LVS) Is Down 13.4% After Record Results Meet Macau Profit Squeeze - What's Changed

In late January 2026, Las Vegas Sands Corp. reported fourth-quarter 2025 revenue of US$3.65 billion and net income of US$395 million, alongside higher earnings per share, a quarterly dividend of US$0.30, and completion of a long-running share repurchase program totaling US$6.54 billion. Despite beating earnings estimates and posting record results at Marina Bay Sands, investor focus turned to weaker profitability in Macau amid tighter Chinese restrictions on high-roller gambling. We’ll now...
BME:ALM
BME:ALMPharmaceuticals

Is China’s Seysara Approval and Sinomune Deal Altering The Investment Case For Almirall (BME:ALM)?

Almirall has reported that China’s National Medical Products Administration approved Seysara (sarecycline hydrochloride) for treating inflammatory lesions of non-nodular moderate-to-severe acne in patients aged 9 and older, with Sinomune holding exclusive commercialization and distribution rights in China. This marks the first approval in China of a tetracycline-derived oral antibiotic developed specifically for dermatology, expanding Seysara’s reach beyond its earlier US launch and...
NasdaqGS:WSFS
NasdaqGS:WSFSBanks

A Look At WSFS Financial (WSFS) Valuation After Earnings Beat And Analyst Upgrades

WSFS Financial (WSFS) is back in focus after fourth quarter 2025 results topped analyst expectations, with commercial lending and wealth management lifting performance and management pointing to ongoing EPS growth supported by active share repurchases. See our latest analysis for WSFS Financial. That strength is showing up in the share price, with WSFS Financial hitting an all time high near its current US$64.73 level and posting a 30 day share price return of 17.58%. The 1 year total...
NasdaqGS:COLL
NasdaqGS:COLLPharmaceuticals

What Collegium Pharmaceutical (COLL)'s Revenue Surge and Low Valuation Means For Shareholders

Collegium Pharmaceutical recently reported strong past revenue growth of 31.40%, supported by robust demand for its pain management products Xtampza ER and Belbuca and a focus on abuse-deterrent formulations. The company’s solid financial health and relatively low forward P/E of 5.71 have drawn increased analyst attention, highlighting its position within the healthcare sector’s pain management niche. Against this backdrop, we’ll examine how Collegium’s robust revenue expansion shapes its...
NasdaqGS:BKNG
NasdaqGS:BKNGHospitality

Stronger Earnings Views And New Corporate Travel Tools Might Change The Case For Investing In Booking Holdings (BKNG)

Recent updates around Booking Holdings highlight upbeat analyst views and rising earnings estimates, alongside new product developments such as KAYAK for Business Events and an expanded Booking.com lodging integration with Navan to streamline corporate travel. Together, these moves show how Booking Holdings is deepening its reach in business travel while using its platforms’ data and connectivity to support corporate clients and travelers. We’ll now explore how this combination of stronger...
NYSE:TT
NYSE:TTBuilding

A Look At Trane Technologies (TT) Valuation After A Strong Q4 Beat And 2026 Outlook

Trane Technologies (TT) is back in focus after fourth quarter 2025 results topped revenue and earnings expectations, supported by strong commercial HVAC bookings, a record backlog, and early 2026 guidance that reinforced investor interest. See our latest analysis for Trane Technologies. The strong fourth quarter beat and upbeat 2026 guidance have kept momentum relatively firm, with a 7 day share price return of 6.7% and a 1 year total shareholder return of 17.8%. The 3 year total shareholder...
OM:MYCR
OM:MYCRElectronic

How Investors May Respond To Mycronic (OM:MYCR) Securing New Asian MMX Metrology Order For Mature Nodes

In January 2026, Mycronic AB (publ) reported receiving a US$2,000,000–US$4,000,000 order from a new Asian customer for its MMX metrology system, with delivery scheduled within the same quarter. The deal highlights how Mycronic is extending its SLX-based MMX technology into mature semiconductor nodes, replacing legacy tools while leveraging proven photomask metrology capabilities. Next, we’ll explore how this MMX order from a new Asian customer shapes Mycronic’s investment narrative around...
ENXTBR:KBC
ENXTBR:KBCBanks

Is KBC Group’s (ENXTBR:KBC) Conservative Capital Returns Masking or Revealing Its True Strength?

In recent days, analysts have reiterated positive views on KBC Group, emphasizing its strong profitability, solid capital ratios, and ongoing dividends and buybacks. What stands out is how KBC’s conservative risk approach and continued investment in digital transformation are being framed as core strengths by the analyst community. We’ll now examine how this renewed focus on KBC’s disciplined capital returns shapes the company’s broader investment narrative. Rare earth metals are the new...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Assessing Gibraltar Industries (ROCK) Valuation After Guidance Cut On Sales And Earnings

Gibraltar Industries (ROCK) lowered its earnings guidance for the quarter and full year ending December 31, 2025, cutting expectations for net sales, GAAP EPS, and operating income compared with its prior forecast. See our latest analysis for Gibraltar Industries. The lower guidance comes after a period of mixed performance, with the latest share price at $51.26 and a 90 day share price return of a 15.76% decline. The 1 year total shareholder return of a 12.76% decline and 5 year total...
NYSE:KBR
NYSE:KBRProfessional Services

Assessing KBR (KBR) Valuation After Recent Share Price Reset

What KBR’s recent performance data tells current shareholders KBR (KBR) has been drawing attention after a mixed run in its share performance, with a 5.7% gain over the past month set against a roughly 18.8% decline over the past year. For investors already holding the stock, those return figures, together with KBR’s reported US$8,041.0m in revenue and US$416.0m in net income, raise questions about how the current share price reflects the company’s underlying business. See our latest analysis...
TASE:MGDL
TASE:MGDLInsurance

A Look At Migdal Insurance And Financial Holdings (TASE:MGDL) Valuation After Sector Driven Share Price Gains

Sector driven move puts Migdal in focus Migdal Insurance and Financial Holdings (TASE:MGDL) moved higher alongside other insurance stocks on the Tel Aviv Stock Exchange, as sector sentiment improved following a previous session of weaker insurance performance. See our latest analysis for Migdal Insurance and Financial Holdings. That sector swing comes on top of a strong run, with Migdal’s share price delivering a 4.43% 1 day move and a 39.97% 90 day share price return, while its 1 year total...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

A Look At LivaNova (LIVN) Valuation After KeyBanc Upgrade And Renewed Medtech Optimism

LivaNova (LIVN) is back on investor radars after KeyBanc Capital Markets shifted to a more favorable rating, linking the move to a broadly positive view on Medical Technology stocks. See our latest analysis for LivaNova. The upgrade comes after a period of rebuilding confidence, with the share price at US$65.71 and a 90 day share price return of 21.82% alongside a 1 year total shareholder return of 36.72%. This suggests momentum has picked up recently, even though longer term total...
NYSE:VIRT
NYSE:VIRTCapital Markets

Why Virtu Financial (VIRT) Is Up 10.7% After Record Profitability and Massive Share Buybacks

Virtu Financial, Inc. recently reported full-year 2025 results with revenue of US$3.63 billion and net income of US$468.36 million, alongside a declared quarterly dividend of US$0.24 per share payable in March 2026. The company also completed a large multi-year buyback program totaling about US$1.42 billion for more than half its shares, while posting its highest quarterly adjusted net income since early 2021 and record profitability at Virtu Execution Services. With this backdrop of record...
NasdaqGS:DRVN
NasdaqGS:DRVNConsumer Services

A Look At Driven Brands Holdings (DRVN) Valuation As Concerns Linger Over Sales Growth And Cash Burn

Recent commentary on Driven Brands Holdings (DRVN) has focused on two pressure points: weak same store sales over the past two years and ongoing questions around its pricing and marketing approach. See our latest analysis for Driven Brands Holdings. The share price at US$15.55 reflects a mixed picture, with a 7.24% year to date share price return and a 1 year total shareholder return decline of 4.89%, while the 3 and 5 year total shareholder returns show steeper double digit losses that...
NasdaqGS:AAON
NasdaqGS:AAONBuilding

Should AAON’s (AAON) New Leadership and Credit Expansion Ahead of Earnings Require Action From Investors?

AAON, Inc. is preparing to release its latest quarterly results on February 26, 2026, following a December 2025 leadership change and a new credit extension to support potential growth projects and investments in evolving HVAC technology. Together, the upcoming earnings release, new General Manager appointment, and additional credit capacity highlight management’s focus on operational efficiency and future expansion options. We’ll now examine how the upcoming earnings release and its link to...